Tag | Content |
---|
EnhancerAtlas ID | HS007-08312 |
Organism | Homo sapiens |
Tissue/cell | BE2C |
Coordinate | chr19:40314810-40315870 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Zfx | MA0146.2 | chr19:40315073-40315087 | CAGGCCTCGGCGTC | - | 6.04 |
|
| Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
SE_48502 | chr19:40314047-40317528 | Psoas_Muscle | SE_51388 | chr19:40305087-40317399 | Skeletal_Muscle | SE_56796 | chr19:40314280-40315292 | VACO_400 | SE_56796 | chr19:40315466-40315907 | VACO_400 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH19I039823 | chr19 | 40314220 | 40316892 |
|
Enhancer Sequence | CTTTGCGCAA ACCATTCCAC CACACCGCCC CCGACCCCCA AAACATCCTT CCGTCTTCAG 60 GTCTCAGCTC AGACAGCTCC TAGTCTTCCG GGATGATCTT CCTACCAAGG TCTCCTCGGG 120 TTCCCACCGC GTTCCATGCC GCCTCCATTA GTGAACATAC ATAGGTCCGC AACGGGGTCT 180 TGCCTGTCTC TCCCACTGAG CGGGGCTTCC CGCAAGCCGG GCCAGGCACA GCGGCCAGTG 240 ATGTCCGCGT GCTGGGGCCT CTTCAGGCCT CGGCGTCTAC TGCCCGCTCT GGAACTGTGA 300 GCGACAACCG GCACTCTCTC CCGGGACGGC GCCGCACCCA CCTTCTGCAC ACCTCGGAGA 360 CCTCAACACC TGCGCCAAAG CCACCCAGTC ACAGCCTTCT CTCCCTCTCC TAAACACCAT 420 GAACATCCAG GCCCCGGGAC CTCAGACTGC TCATTGGCTG CCTGAAAACC CGCCCCCAAG 480 CCTGAGAGAA AAGAACTCTG GTTGCTGTAG TTCCCCAACG AACACCGCAG AAAGCGATTG 540 CTAAGTAGAA CTTCATTTCC CACAAAGCGC CGAGCCCCAG TGGTGGCAGA CGGTACCCTT 600 TGAACTGGGC TCTTGATTGG CCGGTTGGGA GACGTACATT TCCAAATTAC CGTGGAAACA 660 GGACCACTTA CCTGGAACCC CGGGAAAATC TTTTTGTCTC AGAATCTCAA AACTCTTTGT 720 TTCGCGATGA TTCCAAAGAG CTGGACAGTA CACGTGGGGA CAGAGTCTGT ACCTATTGTC 780 TGCCTGTTCC CCAGATGGCA CCAACAAAGC CTCCTAAGTG TACTCAGCTG CTACTGGACG 840 CCTGCTTGGC ATGAGGAGCC ACTCTTGTGC TAAGTCTGCG GACGCCCCGG CTTATTAGGG 900 CACCTGTTTC CCAGAGACAG GCCAGAGCTG AACCTTTACC CTTTCAGGGT CTATTTACCC 960 AGGAAAAGGC AAATGTAGGC CAGGATCCTG TCCACGATCT ATCTAGAATG CTGATGCCCC 1020 AGACCTGCAG ACTCATGCCT GCAACACGCG CCACAGCTTC 1060
|